Search
for

    Sort by

    Research 331–360 of 1000+

    1. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    2. Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study Urologic Oncology: Seminars and Original Investigations · 2018 · 13 citations
    3. Common urologic diseases in older men and their treatment: how they impact fertility Fertility and Sterility · 2017 · 8 citations
    4. An update on the use of 5alpha-reductase inhibitors Drugs of today · 2004 · 7 citations
    5. Clinical use of 5α-reductase inhibitors Cambridge University Press eBooks · 2001 · 3 citations
    6. Modulation of AR-FGF-2-TGF beta Axis by Cosmos caudatus Suppresses Prostatic Epithelial Proliferation in a BPH Rat Model: A Comparative Study with Finasteride Journal of Multidisciplinary Applied Natural Science · 2026
    7. Study on the mechanism that SNPs related to sex hormone metabolism regulate the imbalance of sex hormones and lead to BPH in rats 2025
    8. PD59-09 PHOSPHODIESTERASE INHIBITORS COULD REVERSE THE PROLIFERATION OF BPH EPITHELIAL CELLS INDUCED BY CD8+ T CELLS IN LOW ANDROGEN CONDITION The Journal of Urology · 2018
    9. PD23-01 INHIBITOR OF 5A-REDUCTASE TYPES II PROMOTES THE INFILTRATION OF CD8+T CELLS IN BPH TISSUES. The Journal of Urology · 2014
    10. Influence of tamsulosin and finasteride on circadian rhythm and cardiac function in male elderly patients with chronic heart failure Shiyong laonian yixue · 2014
    11. Experience of using of Sonirid Duo in treatment of patients with BPH Urology reports (St - Petersburg) · 2013
    12. Efficacy and safety of long-term administration of tamsulosin hydrochloride in patients with LUTS suggestive of BPH Zhonghua miniao waike zazhi · 2010
    13. “EGGS AT TWELVE”, HOW GIRLS BECOME BOYS AND THE DISCOVERY OF FINASTERIDE The Journal of Urology · 2009
    14. Faculty Opinions recommendation of Association between 5-alpha reductase inhibition and risk of hip fracture. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008
    15. 走进非洲传统医药学宝库IV:与良性前列腺肥大、农民利益、品种灭绝、国际法规和巨大经济效益休戚相关的非洲李 国外医药:植物药分册 · 2005
    16. Analysis of Cost-effectiveness of 4 Kinds of Projects for Drug Therapy in the Treatment of BPH Zhongguo yiyuan yongyao pingjia yu fenxi · 2004
    17. Androgen antagonists in androgen target tissues Pharmacology & Therapeutics · 1984 · 27 citations
    18. Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis The World Journal of Men's Health · 2019 · 4 citations
    19. Six weeks finasteride monotherapy before TURP: Does it improve quality of life in early post operative period? African Journal of Urology · 2018 · 3 citations
    20. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor Daehan namseong gwahag hoeji · 2012 · 1 citations
    21. Finasteride treatment and neuroactive steroid formation. PubMed · 2009 · 9 citations
    22. Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática Actas Urológicas Españolas · 2006
    23. 5α-reductase inhibitors/finasteride The Prostate · 1996 · 24 citations
    24. Finasteride: a 5 alpha-reductase inhibitor. PubMed · 1993 · 12 citations
    25. Proscar and Propecia—A Therapeutic Perspective The Journal of Clinical Endocrinology & Metabolism · 2004 · 8 citations
    26. 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR European Urology Supplements · 2011
    27. 5alpha-reductase inhibitors/finasteride. PubMed · 1996 · 4 citations
    28. Effects of Finasteride on Vascular Endothelial Growth Factor Scandinavian Journal of Urology and Nephrology · 2002 · 35 citations
    29. Evaluation of men on finasteride. PubMed · 1996 · 3 citations
    30. Risk factors for prostate cancer: a case‐control study in Greece International Journal of Cancer · 1999 · 14 citations